Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pathology

The Biology and Diagnosis of IgG4-RPF

At a Glance

IgG4-related retroperitoneal fibrosis (IgG4-RPF) is an immune system disorder that creates abnormal scar tissue in the abdomen. A biopsy is required to diagnose it, as doctors must look for specific IgG4 antibodies under a microscope to distinguish it from cancers or other diseases.

Understanding the biology of IgG4-related retroperitoneal fibrosis (IgG4-RPF) helps explain why your body is creating scar tissue where it shouldn’t. While the name focuses on IgG4 (an antibody), the disease is actually driven by a complex “conversation” between different parts of your immune system.

The Biological “False Alarm”

In a healthy body, your immune system uses inflammation to heal wounds. In IgG4-RD, this process gets stuck in the “on” position.

  1. The Drivers (T-cells): Specialized immune cells called cytotoxic CD4+ T cells and follicular helper T cells enter the retroperitoneal tissue [1][2]. These cells send out chemical signals (cytokines) that act like a false alarm, telling the body there is a major injury that needs fixing [3].
  2. The Builders (Fibroblasts): In response to these signals, “builder” cells called fibroblasts become hyperactive [3]. They begin churning out dense, ropey collagen—essentially creating a massive internal scar [1].
  3. The Markers (B-cells & Plasma Cells): Another group of cells, B-cells, transform into plasma cells that produce IgG4 antibodies [4][5]. While we don’t think the IgG4 antibodies themselves cause the damage, they serve as a critical “fingerprint” that doctors use to identify the disease [5][6].

Differentiating the “Mimics”

Because many conditions can cause a mass to grow in the back of the abdomen, a biopsy (taking a small tissue sample) is the gold standard for diagnosis [7][8]. Doctors must rule out two main “mimics”:

  • Idiopathic Retroperitoneal Fibrosis (Ormond’s Disease): This looks almost identical to IgG4-RPF on a CT scan. However, when viewed under a microscope, idiopathic RPF lacks the high concentration of IgG4-positive plasma cells and the specific “woven” (storiform) pattern of scar tissue found in IgG4-RPF [5][6].
  • Malignancies (Cancer): Certain cancers, such as lymphoma or metastatic tumors, can also cause retroperitoneal masses [7][9]. A biopsy allows pathologists to look for malignant (cancerous) cells versus the inflammatory cells typical of IgG4-RPF [8].

Because IgG4-RD is a systemic disease (meaning it can affect the whole body), your doctor will often order imaging of your chest, pancreas, or salivary glands to look for inflammation in those organs [10][11]. Finding the disease in multiple organs strongly supports the diagnosis of IgG4-RD and helps rule out an isolated cancer [12].

The 2023 Revised Diagnostic Criteria

In 2023, international experts updated the diagnostic criteria specifically for IgG4-related cardiovascular and retroperitoneal disease (IgG4-PA/RPF) to make diagnosis more accurate [13].

The revised criteria are designed to be more “sensitive,” meaning they help doctors catch the disease earlier and in more patients than previous versions [13]. Key updates include:

  • Extra-organ Clues: If you have signs of IgG4-related disease in other organs (like the pancreas or salivary glands), it now counts more heavily toward a definitive diagnosis of the retroperitoneal mass [13].
  • Radiological Markers: New specific imaging findings, such as inflammation around the heart (pericarditis), have been added as supporting evidence [13].
  • Microscopic Details: The criteria now include very specific microscopic findings, such as the presence of eosinophils (a type of white blood cell) or lymphoid follicles in the tissue [13].

By using these updated rules, your medical team can more confidently distinguish IgG4-RPF from other conditions and start the correct treatment faster.

Common questions in this guide

What causes the scar tissue in IgG4-RPF?
In IgG4-RPF, your immune system acts like a false alarm has been triggered. Specialized T-cells send signals that cause builder cells, called fibroblasts, to become hyperactive and produce dense, ropey scar tissue in your abdomen.
Why do I need a biopsy if I have a retroperitoneal mass?
A biopsy is the gold standard for diagnosing IgG4-RPF because many conditions, including certain cancers and Ormond's disease, can look identical on a CT scan. Examining the tissue under a microscope allows doctors to look for the specific IgG4-positive plasma cells and scar patterns unique to this disease.
What are the 2023 revised diagnostic criteria for IgG4-RPF?
The 2023 criteria are updated international guidelines that help doctors diagnose IgG4-RPF more accurately. They place greater emphasis on signs of inflammation in other organs, specific radiological markers like pericarditis, and detailed microscopic findings in your biopsy.
Can IgG4-related disease affect other organs besides my abdomen?
Yes, IgG4-related disease is a systemic condition that can affect the whole body. Doctors will often scan your chest, pancreas, and salivary glands to check for inflammation, which strongly supports an IgG4-RPF diagnosis over an isolated cancer.

Get notified when new evidence is published on IgG4-related retroperitoneal fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Immune mechanisms of fibrosis and inflammation in IgG4-related disease.

    Pillai S, Perugino C, Kaneko N

    Current opinion in rheumatology 2020; (32(2)):146-151 doi:10.1097/BOR.0000000000000686.

    PMID: 31842033
  2. 2

    Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease.

    Akiyama M, Suzuki K, Yoshimoto K, et al.

    Frontiers in immunology 2021; (12()):651357 doi:10.3389/fimmu.2021.651357.

    PMID: 33936071
  3. 3

    The function of IL-33/ST2 signaling axis in treg cells activating fibrosis in IgG4-related disease.

    Wu Y, Liu J, Yu T, et al.

    Human immunology 2022; (83(4)):295-305 doi:10.1016/j.humimm.2022.01.009.

    PMID: 35067387
  4. 4

    Immune dysregulation in immunoglobulin G4-related disease.

    Maehara T, Koga R, Nakamura S

    The Japanese dental science review 2023; (59()):1-7 doi:10.1016/j.jdsr.2022.12.002.

    PMID: 36654676
  5. 5

    IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.

    Lomborg N, Jakobsen M, Bode CS, Junker P

    Scandinavian journal of rheumatology 2019; (48(4)):320-325 doi:10.1080/03009742.2018.1551963.

    PMID: 30931680
  6. 6

    Differential Diagnosis: Retroperitoneal Fibrosis and Oncological Diseases.

    Sica A, Casale B, Spada A, et al.

    Open medicine (Warsaw, Poland) 2018; (15()):22-26 doi:10.1515/med-2020-0005.

    PMID: 31922016
  7. 7

    Anterior hypopituitarism secondary to biopsy-proven IgG4-related hypophysitis in a young man.

    Joshi H, Hikmat M, Devadass AP, et al.

    Endocrinology, diabetes & metabolism case reports 2019; (2019()).

    PMID: 30943450
  8. 8

    [A CASE OF RENAL HILAR TUMORS IN IGG4-RELATED DISEASE].

    Uehara K, Shibata Y, Washimi K, Osaka K

    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 2024; (115(3)):134-137 doi:10.5980/jpnjurol.115.134.

    PMID: 40691084
  9. 9

    No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases.

    Forestier A, Buob D, Mirault T, et al.

    Clinical and experimental rheumatology 2018; (36(3)):371-375.

    PMID: 29465374
  10. 10

    Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis.

    Yachoui R, Sehgal R, Carmichael B

    Clinical rheumatology 2016; (35(2)):401-7 doi:10.1007/s10067-015-3022-y.

    PMID: 26208444
  11. 11

    IgG4 related disease as a cause of isolated retroperitoneal fibrosis with no other organ involvement; Case report.

    Razok A, Malik R, Cackamvalli P, Zahid M

    Annals of medicine and surgery (2012) 2021; (61()):69-72 doi:10.1016/j.amsu.2020.12.028.

    PMID: 33408856
  12. 12

    IgG4-Related Disease: Endocrine Involvement, Clinical Implications, and Management Strategies.

    Mohamed MA, Hammoud A, Jaber HM, et al.

    Discoveries (Craiova, Romania) 2025; (13(4)):e219 doi:10.15190/d.2025.18.

    PMID: 41555933
  13. 13

    Validation of the Diagnostic Criteria for IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis (IgG4PA/RPF) 2018, and Proposal of a Revised 2023 Version for IgG4-Related Cardiovascular/Retroperitoneal Disease.

    Mizushima I, Morikage N, Ito E, et al.

    Circulation journal : official journal of the Japanese Circulation Society 2024; (88(10)):1679-1688 doi:10.1253/circj.CJ-24-0026.

    PMID: 38494710

This page explains the biology and diagnosis of IgG4-RPF for educational purposes only. Always consult your medical team to interpret your specific biopsy results and imaging tests.